Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Weiss

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Health Economics Review|October 21, 2016
Erratum to: Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of VirginiaRobert Weiss
Health News (Waltham, Mass.)|June 28, 2002
Vanquishing varicose veins. Less invasive techniques work well and slash recovery timeRobert Weiss
Vascular Health and Risk Management|March 1, 2007
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationRobert Weiss
Evidence-Based Medicine|January 11, 2007
Review: Beta blockers differ in their efficacy for preventing major cardiovascular events in younger and older patientsRobert Weiss
ACP Journal Club|November 4, 2006
Review: beta-blockers differ in their efficacy for preventing major cardiovascular events in younger and older patientsRobert Weiss
Journal of the American College of Surgeons|June 25, 2013
Prevention of lymphedemaRobert Weiss
Health Economics Review|July 23, 2022
Cost of a lymphedema treatment mandate - 16 years of experience in the Commonwealth of VirginiaRobert Weiss
Future Cardiology|October 7, 2009
Nebivolol: novel beta-blocker with nitric oxide-induced vasodilationRobert Weiss
Health Economics Review|September 4, 2016
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of VirginiaRobert Weiss
Journal of Vascular Surgery|February 23, 2023
Endovascular aneurysm repair for every ruptured abdominal aortic aneurysm-a rapidly approaching futureRobert Weiss, Ross Milner
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Health Economics Review|October 21, 2016
Erratum to: Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of VirginiaRobert Weiss
Health News (Waltham, Mass.)|June 28, 2002
Vanquishing varicose veins. Less invasive techniques work well and slash recovery timeRobert Weiss
Vascular Health and Risk Management|March 1, 2007
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationRobert Weiss
Evidence-Based Medicine|January 11, 2007
Review: Beta blockers differ in their efficacy for preventing major cardiovascular events in younger and older patientsRobert Weiss
ACP Journal Club|November 4, 2006
Review: beta-blockers differ in their efficacy for preventing major cardiovascular events in younger and older patientsRobert Weiss
Journal of the American College of Surgeons|June 25, 2013
Prevention of lymphedemaRobert Weiss
Health Economics Review|July 23, 2022
Cost of a lymphedema treatment mandate - 16 years of experience in the Commonwealth of VirginiaRobert Weiss
Future Cardiology|October 7, 2009
Nebivolol: novel beta-blocker with nitric oxide-induced vasodilationRobert Weiss
Health Economics Review|September 4, 2016
Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of VirginiaRobert Weiss
Journal of Vascular Surgery|February 23, 2023
Endovascular aneurysm repair for every ruptured abdominal aortic aneurysm-a rapidly approaching futureRobert Weiss, Ross Milner
Pageof 18